Washington- Biden administration mentioned that they are all set to help India with the required raw materials for the coronavirus vaccine production. However, the country works to counter the surge of Covid-19 infections.
In the current week, India now grappled with a staggering rise in a new coronavirus infection. This weekend, India has now marked the global record for the daily cases which is bringing the nation’s cumulative total of almost 16,960,172 cases, as per the figures compared by Johns Hopkins.
National Security Council spokeswoman Emily Horne said, “Just as India sent assistance to the United States as our hospitals were strained early in the pandemic, the United States is determined to help India in its time of need.”
Even Horne has also added that the United States might be sent raw materials required for Indian for manufacturing the Covishield vaccine, as well as therapeutics, rapid diagnostic test kits, ventilators, and protective equipment.
Horne added that the U.S. would also send a team of public health advisors from the Center for Disease Control and USAID to India, “The U.S. Development Finance Corporation is funding a substantial expansion of manufacturing capability for BioE, the vaccine manufacturer in India, enabling BioE to ramp up to produce at least 1 billion doses of Covid-19 vaccines by the end of 2022.”
The U.S. response comes after Britain, Germany and France pledged to benefit India over the weekend.
On Sunday, Biden mentioned in a tweet “determined to help India in its time of need.”
In the last week, the United States administrated a new record of 200 million doses of the coronavirus vaccine. Biden told the reporters that his administration was looking at more ways to benefit internationally.
On 21st April, Biden mentioned, “We’re looking at what is going to be done with some of the vaccines that we are not using. We’re going to make sure they are safe to be sent. We don’t have enough to be confident to send it abroad now. But I expect we’re going to be able to do that.”